Wolff Wiese Magana’s iRadimed IRMD Stock Holding History

Wolff Wiese Magana’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.58K	Buy	27 +12	+80%	+$1.09K	﹤0.01%	776
2026 Q1	$1.44K	Buy	+15	New	+$1.5K	﹤0.01%	824

Other funds holding IRMD

Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Wolff Wiese Magana's IRMD Position: Q2 2026 in Review

Wolff Wiese Magana increased its iRadimed (IRMD) stake by 80% in Q2 2026, buying an estimated $1.09K and bringing the position to 27 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Wolff Wiese Magana first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Wolff Wiese Magana held 27 shares of iRadimed worth $2.58K as of Q2 2026.
Wolff Wiese Magana bought 12 iRadimed shares in Q2 2026, an estimated $1.09K.
iRadimed made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #776 holding.
Wolff Wiese Magana first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
22 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.